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ARTICLE
Impact of in vitro digestion on gastrointestinal fate and uptake of silver
nanoparticles with different surface modifications
Ashraf Abdelkhaliqa,b,c, Meike van der Zandea, Anna K. Undasa, Ruud J. B. Petersa and
Hans Bouwmeesterb
aWageningen Food Safety Research, Wageningen, The Netherlands; bDivision of Toxicology, Wageningen University, Wageningen,
The Netherlands; cFood Science and Technology Department, Faculty of Agriculture, Alexandria University, Alexandria, Egypt
ABSTRACT
Nanomaterials, especially silver nanoparticles (AgNPs), are used in a broad range of products
owing to their antimicrobial potential. Oral ingestion is considered as a main exposure route to
AgNPs. This study aimed to investigate the impact of the biochemical conditions within the
human digestive tract on the intestinal fate of AgNPs across an intestinal in vitro model of differ-
entiated Caco-2/HT29-MTX cells. The co-culture model was exposed to different concentrations
(250–2500mg/L) of pristine and in vitro digested (IVD) AgNPs and silver nitrate for 24h. ICP-MS
and spICP-MS measurements were performed for quantification of total Ag and AgNPs. The
AgNPs size distribution, dissolution, and particle concentration (mass- and number-based) were
characterized in the cell fraction and in the apical and basolateral compartments of the mono-
layer cultures. A significant fraction of the AgNPs dissolved (86–92% and 48–70%) during the
digestion. Cellular exposure to increasing concentrations of pristine or IVD AgNPs resulted in a
concentration dependent increase of total Ag and AgNPs content in the cellular fractions. The
cellular concentrations were significantly lower following exposure to IVD AgNPs compared to
the pristine AgNPs. Transport of silver as either total Ag or AgNPs was limited (<0.1%) following
exposure to pristine and IVD AgNPs. We conclude that the surface chemistry of AgNPs and their
digestion influence their dissolution properties, uptake/association with the Caco-2/HT29-MTX
monolayer. This highlights the need to take in vitro digestion into account when studying nano-
particle toxicokinetics and toxicodynamics in cellular in vitro model systems.
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Introduction
Nanomaterials are used in a broad range of products
and applications such as textiles, medical devices,
water disinfection, personal hygiene and food prod-
ucts (Abdelkhaliq et al. 2018; Chaudhry et al. 2008;
Imai et al. 2017; Lichtenstein et al. 2015). Because of
the antimicrobial potential of silver nanoparticles
(AgNPs), they are amongst the most frequently used
nanoparticles (NPs) in food associated products (e.g.
packaging and kitchen utensils) (Choi et al. 2018;
Lichtenstein et al. 2015). Therefore, oral ingestion is
considered as a main exposure route for humans to
AgNPs. From a risk assessment perspective, under-
standing the fate, cellular interactions (i.e. cellular
uptake) and bioavailability of AgNPs upon digestion
is of key importance to assess their impact on health
(Bouwmeester et al. 2011; Hsiao et al. 2016;
Lichtenstein et al. 2015, 2017)
Upon oral ingestion of AgNPs, these particles pass
through several compartments of the gastrointestinal
tract (mouth, stomach and intestine), each with a spe-
cific pH and biochemical composition. These varying
conditions can affect the AgNPs physicochemical
properties (e.g. agglomeration and dissolution) and
accordingly affect their bioavailability and toxico-
logical properties (B€ohmert et al. 2014; Lichtenstein
et al. 2017; Murdock et al. 2008; Sieg et al. 2017). Upon
reaching the intestine, the biological interactions (e.g.
uptake and transport) of the AgNPs with the intestinal
epithelial cells determine their bioavailability and
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possible subsequent systemic effects upon oral inges-
tion (McCracken et al. 2015). AgNPs size and surface
chemistry play an important role in their stability, cel-
lular internalization, and transport (Lichtenstein et al.
2017; Mwilu et al. 2013). Several in vitro models have
been developed to represent the intestinal epithelial
barrier (Lefebvre et al. 2015) which are exposed to NPs
to simulate real-life human exposure conditions to
NPs (Nel et al. 2006; Sieg et al. 2017). Among these
model, the co-cultures of monolayers of Caco-2 intes-
tinal cells and HT29-MTX mucus secreting cells are
widely used as an in vitro intestinal epithelium model
(Bailey, Bryla, and Malick 1996; Georgantzopoulou
et al. 2015; Lefebvre et al. 2015; Stone, Johnston, and
Schins 2009). These models however do not consider
possible effects of digestion on toxicokinetics and tox-
icodynamics of NPs.
Detection, characterization, and quantification of
(metal) nanoparticles are of importance in studying
the fate of NPs. For this, several analytical methods
have been developed (Lopez-Serrano et al. 2014).
Single particle-inductively coupled plasma mass
spectrometry (spICP-MS) has shown high efficacy
and sensitivity to detect NPs at low concentrations
in addition to its ability to distinguish between metal
ions and NPs (Abdolahpur Monikh et al. 2019; Ding
et al. 2018; van der Zande et al. 2016; Weigel et al.
2017). In addition, spICP-MS provides information on
the size, size distribution, and mass- and number-
based NPs concentration (Hsiao et al. 2016; Laborda
et al. 2011; Peters et al. 2015). To study the cellular
uptake and internalization of AgNPs, however, add-
itional techniques need to be used. For this we used
confocal fluorescence microscopy exploiting the light
scattering properties of AgNPs in combination with
immunohistochemistry (Kittler et al. 2010; van der
Zande et al. 2016). Here, we aimed to investigate the
impact of in vitro digestion (IVD) on two 50nm
AgNPs with different surface chemistries, while silver
nitrate (AgNO3) was used as an ionic control. An in
vitro human digestion model was used to mimic the
oral, gastric, and small intestinal conditions
(Lichtenstein et al. 2015; Versantvoort et al. 2005;
Walczak et al. 2012). The size, size distribution, dissol-
ution, and particle concentration (mass- and num-
ber-based) of the AgNPs after in vitro digestion using
spICP-MS and ICP-MS were measured and quantified.
Also, we investigated the impact of in vitro diges-
tion on the uptake/association and transport of the
AgNPs in or through the intestinal barrier using an
in vitro Caco-2 and HT29-MTX co-culture trans-
well model.
Materials and methods
Nanoparticles and chemicals
Two 50 nm negatively charged AgNPs with different
surface modifications were purchased from
Nanocomposix Inc. (San diego, CA, USA); lipoic acid
BioPureTM (pH 6.1) in milli-Q water and citrate
BioPureTM (pH 7.4) in 2mM citrate buffer, further
referred to as (LA) and (Cit) AgNPs, respectively. The
silver mass concentration in the stock suspensions of
both AgNPs was 1mg/mL. All the AgNPs suspensions
were stored at 4 C in the dark. Dilutions of the
AgNPs were freshly prepared for every experiment in
complete cell culture medium (DMEMþ), prepared by
supplementing Dulbecco’s Modified Eagle Medium
(DMEM) culture medium (LONZA, Basel, Switzerland)
with 10% (v/v) heat inactivated Fetal Bovine Serum
(FBS) (GibcoVR , Life technologies, USA), 1% (v/v) of
Penicillin–Streptomycin 10 000 units penicillin, and
10mg streptomycin/mL (Sigma-Aldrich, St Louis, MO,
USA), and 1% (v/v) of MEM Non-Essential Amino
Acids (NEAA) (GibcoVR , life technologies, Langley, OK,
USA). Silver nitrate (AgNO3) (Sigma, USA) was used as
a control (source of Agþ ions) in all the experiments.
Dilutions of AgNO3 were freshly prepared for every
experiment in DMEMþ.
Physicochemical characterization of nanoparticles
Hydrodynamic diameters of AgNPs were determined
using dynamic light scattering (DLS). Measurements
were performed on samples containing 10mg/L
AgNPs suspended in nano-pure water using an ALV
dynamic light scattering setup (ALV-Laser
Vertriebsgesellschaft, Langen, Germany), consisting
of a Thorn RFIB263KF photomultiplier detector, an
ALV-SP/86 goniometer, an ALV 50/100/200/400/
600 lm pinhole detection system, an ALV7002 exter-
nal correlator, and a Cobolt Samba-300 DPSS laser.
Measurements were performed at t¼ 0 h and at
t¼ 24 h at room temperature, samples were incu-
bated at 37 C. For each condition, samples were ana-
lyzed in triplicate; each measurement consisted of 10
technical replicates measurements of 30 s each, at an
angle of 90. The results are expressed as the average
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hydrodynamic diameter (nm) ± standard deviation
(SD) that was calculated using AfterALVVR software
(AfterALV 1.0d, Dullware, USA).
The AgNPs surface charges were determined by
measuring the zeta-potential of 10mg/mL AgNPs
suspensions in nano-pure water using a Malvern
Nanosizer (Malvern Instruments, UK). All samples
were analyzed in triplicate.
The total silver content of pristine AgNPs suspen-
sions and AgNO3 solution was analyzed using a
NexION 350D (PerkinElmer, Waltham, MA, USA) ICP-
MS. Before analysis, samples were digested using an
aqua-regia [1:3 (v/v), 70% HNO3: 37% HCl] acid
digestion for 30min at 60 C and diluted with nano-
pure water. Silver was measured using the selected
element-monitoring mode with m/z values of 107
and 109. A matrix-matched calibration curve of an
ionic Ag standard (AgNO3) (Merck, Darmstadt,
Germany) ranging from 0.1 to 50 mg/L was included.
Rhodium (Merck, Germany) was used as an internal
standard. The limit of detection (LODconc) and limit
of quantification (LOQconc) were 4 and 13.5 ng/L
respectively and they were calculated by the meas-
urement of blank samples as mass concentration in
the blank þ 3 SD and 10 SD respectively. All
samples were analyzed in triplicate.
The particle size, size distribution, mass- and
number-based particle concentration of pristine
AgNPs suspensions and AgNO3 solution were quan-
tified using spICP-MS. The method for the spICP-MS
measurements was described previously (Peters
et al. 2015). Briefly, the sample flow rate to the
nebulizer was determined before the start of each
series of measurements. The dwell time was set at
3ms and the total acquisition time was set at 60 s.
A diluted suspension of 60 nm gold NPs
(Nanocomposix, USA) with a mass concentration of
50 ng/L was used before each analysis to verify the
performance of the ICP-MS and to determine the
transport efficiency. A calibration curve of ionic sil-
ver (AgNO3) with a concentration range of
0.1–20 mg/L was used. The time scan data of the
spICP-MS measurements were exported as .csv files,
and the calculation of the particle size, size distribu-
tion, and mass- and number-based concentrations
from the spICP-MS data were performed using a
dedicated spreadsheet. Details about the spread-
sheet have been described previously (Peters et al.
2015). The LODconc and LOQconc were estimated to
be 22 and 75 ng/L respectively and they were calcu-
lated by the measurement of blank samples as
mass concentration in the blank þ 3 SD and
10 SD respectively. The NP size was calculated
based on the particle mass, assuming spherical par-
ticles. The size detection limit (LODsize) was 20 nm
and accordingly any silver particles with sizes below
this limit were included in the ionic silver fraction.
In vitro digestion of AgNPs and AgNO3
The two AgNPs suspensions and the AgNO3 solu-
tion were digested using an in vitro human gastro-
intestinal digestion model with a pH gradient
ranging from 7 (mouth), to 5 (stomach), to 7 (intes-
tine). The pH of 5 in the stomach is meant to
resemble the conditions upon food consumption
which leads to a decrease of stomach acidity,
opposed to a pH of 2 under fasted conditions
(Minekus et al. 2014). Briefly, all digestive juices
were freshly prepared and warmed to 37 C before
use as described in Table 1 (Versantvoort et al.
2005; Walczak et al. 2012).
Table 1. Composition of the artificial digestion fluids of the in vitro digestion model (per 1000mL) (Versantvoort et al. 2005;
Walczak et al. 2012).
Saliva (pH 6.8 ± 0.1) Gastric fluid (pH 1.3 ± 0.1) Duodenal fluid (pH 8.1 ± 0.1) Bile fluid (pH 8.2 ± 0.1)
 896mg KCl
 200mg KSCN
 1021mg NaH2PO4H2O
 570mg Na2SO4
 298mg NaCl
 1694mg NaHCO3
 200mg urea
 290mg amylase
 15mg uric acid
 25mg mucin
 Nano-pure water
 2752mg NaCl
 306mg NaH2PO4H2O
 824mg KCl
 302mg CaCl2
 306mg NH4Cl
 6.5mL 37% HCl
 650mg glucose
 20mg glucuronic acid
 85mg urea
 330mg glucosamine-hydrochloride
 1 g BSA
 2.5 g pepsin
 3 g mucin
 Nano-pure water
 7012mg NaCl
 3388mg NaHCO3
 80mg KH2PO4
 564mg KCl
 50mg MgCl26H2O
 180mL HCl (37%)
 100mg urea
 151mg CaCl2
 1 g BSA
 9 g pancreatin
 1.5 g lipase
 Nano-pure water
 5259mg NaCl
 5785mg NaHCO3
 376mg KCl
 150mL HCl (37%)
 250mg urea
 167.5mg CaCl2
 1.8 g BSA
 30 g bile
 Nano-pure water
Sodium carbonate solution
 84.7 g NaHCO3
 Nano-pure water
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A volume of 1mL, with a concentration of
500mg/L of AgNPs suspensions or 95mg/L AgNO3
solution, was mixed with 3mL of saliva
(pH 6.8 ± 0.1) and incubated (head-over-heals at
55 rpm) for 5min at 37 C to simulate the digestion
in the mouth. Subsequently, 6mL of gastric juice
(pH 1.3 ± 0.1) was added to the mixture and the pH
was checked and adjusted to 5 ± 0.5 with NaOH
(5M) to simulate the digestion in the stomach. The
samples were further incubated while rotating at
head-over-heals at 37 C for 2 h. Lastly, 6mL of duo-
denal juice (pH 8.1) and 3mL of bile (pH 8.2) were
added to the mixture and the pH was checked and
adjusted to 6.5 ± 0.5 with NaOH (1M) or HCl (37%)
to simulate the digestion in the small intestine.
Again, the samples were incubated while rotating
head-over-heals at 37 C for 2 h. The complete mix-
ture of all the digestive juices is further referred to
as chyme.
The total silver content of the IVD AgNPs suspen-
sions and AgNO3 solution was analyzed using ICP-
MS as described earlier. spICP-MS measurements
were used to quantify the particle size, size distribu-
tion, and mass- and number-based concentrations
of the IVD AgNPs suspensions and AgNO3 solution
as described earlier. The silver ions calibration
curves were prepared in a similar matrix as the
samples of interest.
Cell culture
A co-culture of adherent human epithelial colorectal
adenocarcinoma cells (Caco-2; ATCCVR HTB-37TM;
USA) and human colon adenocarcinoma mucus
secreting cells (HT29-MTX; ECACC, Ireland) was pre-
pared of cells at passage numbers of 25–40 and
8–40, respectively. Both cell lines were cultured and
separately maintained in 75 cm2 cell culture flasks
(CorningVR ; Corning, NY, USA) at 37 C in a humidi-
fied 5% CO2 atmosphere in DMEM
þ.
Cell viability
Cytotoxic effects of the pristine and IVD AgNPs and
AgNO3 were determined using the WST-1 cell viabil-
ity assay (Roche, Basel, Switserland). Each well was
seeded with 100 ml of a 1 105 cells/mL suspension
with a 3:1 ratio Caco-2: HT29-MTX in DMEMþ in 96-
well flat bottom plates (Grenier bio-one, Alphen aan
den Rijn, The Netherlands). Plates were incubated at
37 C, 5% CO2 for 24 h. The attached cells were
then exposed to 100 mL/well of freshly prepared
dilutions (100–100,000mg/L) of pristine and
(500–2500 mg/L) IVD AgNPs suspensions and/or
(125–500 mg/L) AgNO3 solution. All the IVD AgNPs
and AgNO3 dilutions had a 9:1 DMEM
þ: chyme
ratio, to prevent toxicity of the chyme. After 24 h of
exposure, the exposure medium was discarded, and
the cells were washed once with 100 mL/well HBSS
buffer before addition of 10 mL of WST-1 solution
with 90 mL of DMEMþ (without phenol red) to each
well. The plates were incubated for 4 h at 37 C, 5%
CO2 and absorbance was read at 490 and 630 nm
on a plate reader (BioTek SynergyTM HT Multi-Mode
Microplate reader, Winooski, VT, USA). The cell via-
bility was expressed as % of control. DMEMþ was
used as a negative control and Triton-X100 (0.25%)
(Sigma) was used as a positive control.
In vitro intestinal monolayer barrier
integrity assessment
The Caco-2 and HT29-MTX cells were grown in a
ratio of 3:1 (Kleiveland 2015; Walczak, Kramer,
Hendriksen, Helsdingen, et al. 2015a) at a density of
4 x 104 cells/cm2 on the upper side of transwell
polyester inserts (0.4 lm pore size, 1.12 cm2 surface
area) (Corning, USA) for 21 days. The integrity of the
monolayer was assessed before AgNPs exposure by
measuring the transepithelial electrical resistance
(TEER) values using a Millicell ERS-2 Epithelial Volt-
Ohm Meter (Millipore, USA). On day 21, only inserts
with TEER values above 200 X.cm2 before exposure
were used. In addition, a maximum of 20% reduc-
tion in TEER values was accepted after exposure.
Additionally, the transport efficacy of each of
three different integrity markers namely; lucifer yel-
low (LY) (Sigma, USA) and low (4 kDa) and high
(10 kDa) molecular weights fluorescein isothiocyan-
ate dextrans (FITC-D) (Sigma, USA) was evaluated in
the presence and absence of EGTA (a tight-junction
disruptor) (Sigma, USA) to assess the cell monolayer
integrity. In the absence of EGTA, 500 mL/insert of
1mg/mL in DMEMþ of the integrity markers were
added apically. After 1 h incubation at 37 C, the
basolateral medium was collected, and the trans-
port of the markers was determined by measuring
the fluoresce at 485/530 nm using the fluorescence
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plate reader. For samples evaluated in the presence
of EGTA, 500 mL of a solution of 2.5mM EGTA/
DMEMþ was added apically and basolaterally fol-
lowed by incubation of the monolayers for 1 h at
37 C. The wells were then refreshed with 2.5mM
EGTA/DMEMþ solution in the basolateral compart-
ment while apically the integrity markers in DMEMþ
were added at a concentration of 1mg/mL. The
cells were incubated for 1 h at 37 C and the baso-
lateral medium was collected and analyzed for the
presence of the markers as described above.
Cellular uptake/association and transport of
AgNPs and AgNO3
The cellular monolayer was exposed apically to
500 lL/insert of 250, 500, and 2500 mg/L of pristine
or IVD AgNPs suspensions and to 250 mg/L of pris-
tine or IVD AgNO3 solutions for 24 h at 37 C, 5%
CO2. Then, the media from the apical and basolat-
eral compartments were collected and the cells
were collected by trypsinzation and sonication
(40 kHz for 15–20min) to lyse the cells. The total sil-
ver content of all the samples was analyzed using
ICP-MS as described earlier. spICP-MS was used to
quantify the particle size, size distribution, and
mass- and number-based concentrations of all sam-
ples as described above.
Confocal microscopy
For confocal imaging, Caco-2/HT29-MTX co-cultures
were cultured in transwells and exposed to both
pristine and IVD AgNPs suspensions and AgNO3
solution using similar conditions as used in the
uptake/association and transport experiments. After
exposure, the exposure medium was discarded, and
the cells were fixed with 4% paraformaldehyde
(Sigma, USA) for 15min. The cells were washed 3
times with PBS for 5min after discarding the fix-
ation solution. The cells were permeabilized with
0.25% Triton X-100/PBS for 15min. The cells were
then washed again 3 times with PBS for 5min
before incubating them with the blocking buffer
(1% BSA in PBS) for 30min. After discarding the
blocking buffer, Phalloidin – Alexa 488 (6 units)
(Dyomics, Germany) was added to stain cellular
actin and the cells were incubated for 30min. Cells
were washed three times with PBS before
incubating the cells for 10min with RedDot-2
(1:200) (Biotium, USA) to stain the nuclei. Finally,
the cells were washed with PBS and stored in the
dark until analysis. The cells were analyzed using a
confocal laser scanning microscope (SP5X-SMD;
Leica Microsystems, Germany). Samples were
excited with 665 and 495 nm lasers and backscat-
tered light was used to detect AgNPs using a
543 nm laser. All preparations steps have been
done at room temperature.
Transmission electron microscopy energy-
dispersive spectroscopy (TEM-EDS) analysis
Following the 24 h exposure of the Caco-2/HT29-
MTX co-culture to pristine or IVD AgNPs or AgNO3,
samples from the basolateral compartments were
withdrawn. The samples were deposited on a holey
carbon coated Cu TEM grid (Agar Scientific, UK) and
dried at room temperature before examination
using a TEM-EDS system. The grid examination was
performed on a JEM-2100 equipped with EDS sys-
tem of OI Aztec 80mm X-max detector.
Statistical analysis
Each data point of all the experiments performed
represents the average from three replicates (n¼ 3)
and the results are shown as mean± standard devi-
ation after analysis by PrismVR (v.8.0.1; GraphPadVR ,
USA) software. Bonferroni’s post-test was used to
test statistical significance upon performing a one-
way analysis of variance (ANOVA). A p-value< 0.05
was considered significant.
Results
Physicochemical characterization of the pristine
AgNPs suspensions and AgNO3 solution
Two differently coated AgNPs were used in this
study: lipoic acid-coated (LA) AgNPs and citrate-
coated (Cit) AgNPs. The nominal sizes provided by
the supplier of the (LA) and (Cit) AgNPs measured
by transmission electron microscopy (TEM) were
51 ± 5 and 52± 6 nm, respectively. The hydro-
dynamic sizes and the f – potential of both AgNPs,
measured in nano-pure water after 0 and 24 h incu-
bation at 37 C, are listed in Table 2. There were no
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significant differences in the hydrodynamic diame-
ters or the charges of both AgNPs over time.
The suspensions of both AgNPs and AgNO3 were
analyzed as pristine suspensions and after in vitro
digestion (IVD suspensions) to quantify the total sil-
ver content and silver in particulate form (AgNPs)
using ICP-MS and spICP-MS, respectively (Figure 1).
The AgNPs content in the pristine suspensions of
both types of AgNPs was equal to the total Ag con-
tent and corresponded to the theoretical (nominal)
concentration. The pristine solution of AgNO3 did
not contain detectable levels of AgNPs.
Upon IVD, the total Ag content of both AgNPs
suspensions and the AgNO3 solution remained
unchanged (compared to the pristine suspension)
except the highest concentration of AgNPs
(Figure 1(a)). The AgNPs content of both types of
AgNPs was significantly reduced upon digestion at
all concentrations tested. The IVD (LA) AgNPs sus-
pension showed a reduction in particulate silver
(mass-based) between 86 and 92% while the IVD
(Cit) AgNPs suspension showed a reduction between
48 and 70% in particulate silver (mass-based), com-
pared to the pristine suspensions. Interestingly, a low
but significantly elevated concentration of newly
formed silver particulates (de novo) was observed in
the AgNO3 solution upon digestion (Figure 1(b)).
Assessment of AgNPs and AgNO3 cytotoxicity
The viability of the Caco-2/HT29 co-culture was
assessed using the WST-1 assay (cellular mitochon-
drial activity determination) upon 24h exposure to
increasing concentrations of pristine or IVD AgNPs
suspensions and AgNO3 solution (Figure 2). The pris-
tine AgNO3 induced concentration dependent cyto-
toxicity. The cell viability of all the concentrations
used in the subsequent experiments of pristine or
IVD AgNPs suspensions (up to 2500mg/L) and AgNO3
solution (up to 500mg/L) was higher than 85%.
Cellular barrier integrity assessment
For the transport studies, monolayers of Caco-2/
HT29-MTX coculture were grown for 21days in trans-
wells to allow cells to form a tight junction and dif-
ferentiated monolayer. Only monolayers that had
TEER values > 200 X.cm2 were used for subsequent
cellular uptake/association and transport studies. The
monolayer integrity was also confirmed by assessing
the transport of lucifer yellow (LY), and 4 kDa and
10 kDa FITC-dextrans in the presence or absence of a
tight junction disruptor (EGTA). The transport of the
three markers was very limited (< 0.5%) in the
absence of the EGTA, while upon addition of EGTA
Table 2. Physicochemical characteristics of AgNPs.
Medium Incubation time (h)
Hydrodynamic diameter (nm) ± SD f-potential (mV) ± SD
(LA) AgNPs (Cit) AgNPs (LA) AgNPs (Cit) AgNPs
Nano-pure water 0 56 ± 8 51 ± 1 56 ± 10 37 ± 7
24 49 ± 2 48 ± 4 36 ± 10 29 ± 12
Figure 1. Silver content in pristine and in vitro digested (IVD) AgNPs suspensions and AgNO3 solution. (a) Silver content measured
as total Ag using ICP-MS. (b) Silver content measured as AgNPs using spICP-MS. Concentrations are given as the mean± SD
(n¼ 3). Significant difference between the pristine and IVD suspension of the same AgNPs (p< 0.05).
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the transport increased significantly (up to 20- to
140-fold) (Supplementary Material, Figure S1).
Cellular uptake/association of AgNPs and AgNO3
by monolayers of intestinal epithelial cells
Monolayers of 21 days old Caco-2/HT29-MTX cocul-
ture were exposed for 24 h to increasing concentra-
tions of either pristine or IVD AgNPs suspensions or
AgNO3 solution. The resulting cellular uptake/associ-
ation of Ag was quantified and expressed as total
Ag and AgNPs (Figure 3).
The total Ag and AgNPs content in the cell frac-
tion increased in a concentration-dependent man-
ner for both AgNPs irrespective of their treatment
(pristine or IVD) (Figure 3). Upon the pristine AgNPs
exposure, the total Ag contents in the cellular frac-
tion of (LA) AgNPs samples were significantly higher
than that in the (Cit) AgNPs samples (Figure 3(a)).
While the cellular fraction content of AgNPs
exposed to (LA) AgNPs was significantly higher at
the highest concentration compared to (Cit) AgNPs
samples (Figure 3(b)). After IVD, comparable levels
of Ag and AgNPs were detected in the (LA) and
(Cit) AgNPs samples except for the highest concen-
tration where the (Cit) AgNPs samples had a signifi-
cant higher Ag and AgNPs concentrations than the
(LA) AgNPs samples (Figure 3(c,d)).
In the cell fraction samples upon exposure to
both pristine and IVD AgNO3, mainly total Ag was
detected, but after IVD a limited number of AgNPs
was detected.
Figure 2. Cell viability of a Caco-2/HT29-MTX co-culture after 24 h exposure to a concentration range of pristine: (a) (LA) and (Cit)
AgNPs and (b) AgNO3, and IVD; (c) (LA) and (Cit) AgNPs and (d) AgNO3 using the WST-1 viability assay. Viability is given as a per-
centage of the control (mean± SD; n¼ 3). Significant difference between AgNPs at the same concentration (p< 0.05).,#Significant difference between any concentration and the control within the same treatment (p< 0.05).
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In general, the cellular silver contents as total Ag
or AgNPs upon exposure to IVD AgNPs was signifi-
cantly lower compared to exposure to pristine
AgNPs. Confocal microscopy was applied to evalu-
ate cellular internalization of both AgNPs (pristine
or IVD). Various planes through the cells were
assessed showing that clusters of silver or AgNPs
were mainly localized in the cytoplasm and to
some extent in the nucleus (Figure 4).
Transport of AgNPs and AgNO3 across monolayers
of intestinal epithelial cells
The transport of either pristine or IVD AgNPs and
AgNO3 through the Caco-2/HT29-MTX monolayers
was minimal (<0.1%) either as total Ag or AgNPs.
Also, using TEM-EDS no AgNPs could be detected
in samples from the basolateral compartments in
any of the exposure groups. Only in small areas of
the examined grids, an increased number of silver
counts were found, but they were not visible in a
particulate form (data not shown).
spICP-MS size distribution in pristine and IVD
suspensions
The spICP-MS measurements were transformed into
size distribution plots depicting the number of par-
ticles corresponding to each AgNPs diameter cluster
(5 nm) on y- and x-axis, respectively (Figure 5). The
number of particles measured in the AgNPs suspen-
sions and AgNO3 solution are presented in
Supplementary Material, Table S1. There was no
apparent difference in the size distributions of the
pristine suspensions of both AgNPs, with a median
size of 50 nm (Figure 5(a,b)). No AgNPs could be
Figure 3. Silver uptake/adhesion of (LA) and (Cit) AgNPs and AgNO3 in differentiated Caco-2/HT29-MTX cells after 24 h exposure,
measured and expressed as total Ag after (a) exposure to pristine AgNPs and AgNO3; (c) exposure to in vitro digested AgNPs and
AgNO3. Also expressed as AgNPs after (b) exposure to pristine AgNPs and AgNO3; (d) exposure to in vitro digested AgNPs and
AgNO3. Concentrations are given as the mean± SD (n¼ 3). Values with different letters are significantly different at the same con-
centration (p< 0.05).
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Figure 4. Uptake/adhesion of AgNPs after 24 h exposure. Confocal microscopy images of 21-day-old Caco-2/HT29-MTX cells. (a)
without exposure to AgNPs (negative control), after exposure to 2500lg/L, (b) pristine (LA) AgNPs, (c) pristine (Cit) AgNPs, (d) IVD
(LA) AgNPs, and (E) IVD (Cit) AgNPs. Nuclei were stained in red (RedDot-2), actin was stained in green (Alexa-488 Phalloidin) and
AgNPs are shown in white (back scatter).
Figure 5. Number-weighted size distributions generated by spICP-MS measurements in exposure suspensions. (a) 500mg/L pristine
(LA) AgNPs, (b) 500mg/L pristine (Cit) AgNPs, (c) 250mg/L pristine AgNO3, (d) (LA) 500mg/L IVD AgNPs, (e) 500mg/L IVD (Cit)
AgNPs, and (f) 250mg/L IVD AgNO3.
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detected in the pristine solution of AgNO3
(Figure 5(c)).
In vitro digestion affected the size and size distri-
bution of (LA) AgNPs, as the mass–concentration
were reduced (90% lower) compared to the pris-
tine samples (Figure 5(d); also reflected in Figure 1).
In addition, the size distribution curves of the IVD
suspensions showed broadened distributions, indicat-
ing the presence of both smaller and larger particles.
The size distribution of the (Cit) AgNPs was less
affected by in vitro digestion, where the majority of
both the pristine and IVD (Cit) AgNPs had a median
size of 50 nm (Figure 5(b,e)). The total number of
particles was reduced (38% lower) compared to
the pristine particles. Upon in vitro digestion, newly
formed silver particulates (de novo) were found in
the AgNO3 solution with a median size of 25 nm
(Figure 5(f)). All the size distributions of the three
concentrations of AgNPs were following similar
trend, accordingly all the size distributions reported
in Figure 5 are only for of 500mg/L of AgNPs and
250mg/L AgNO3 for simplicity and clarity purposes.
spICP-MS size distribution in cellular fraction
The size distributions (Figure 6) and number of par-
ticles (Supplementary Material, Table S1) of both
AgNPs measured in the cellular fraction were differ-
ent depending on the surface chemistry of the
AgNPs and on whether they were pristine or IVD.
Following exposure to pristine (LA) AgNPs, a broad
size distribution was observed without a clear peak
(Figure 6(a)). This distribution was highly different
from the size distribution in the pristine suspension
(Figure 5(a)). For the pristine (Cit) AgNPs, the cellu-
lar fraction has AgNPs with a median size of 35 nm
and the size distribution (Figure 6(b)) was compar-
able to that of the pristine (Cit) AgNPs suspension
(Figure 5(b)). Among pristine AgNPs, the number of
NPs in the cell fraction exposed to (LA) AgNPs
(3.1 105 ± 4.6 104) was significantly lower than
the number of particles detected in the cells
exposed to (Cit) AgNPs (2.6 106 ± 1.7 105).
The size distribution of IVD (LA) AgNPs in the cell
fraction – compared to the IVD suspension distribu-
tion of these AgNPs (Figure 5(d)) – was right
skewed with a median size of 45 nm (Figure 6(d)).
The broadening of the size distribution and longer
tail showed the appearance of bigger particles
(aggregates) up to 200 nm. The size distribution of
IVD (Cit) AgNPs in the cell fraction (Figure 6(e)) also
showed a longer tail compared to the IVD (Cit)
AgNPs suspension (Figure 5(e)), showing bigger par-
ticles (aggregates) up to 200 nm with a median size
Figure 6. Number-weighted size distributions generated by spICP-MS measurement of Caco-2/HT29-MTX cellular silver content
after 24 h exposure to (a) 500mg/L pristine (LA) AgNPs, (b) 500mg/L pristine 50 nm (Cit) AgNPs, (c) 250mg/L pristine AgNO3, (d)
500mg/L IVD (LA) AgNPs, (e) 500mg/L IVD (Cit) AgNPs, and (f) 250mg/L IVD AgNO3.
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of 50 nm. Among IVD AgNPs, the number of NPs in
the cell fraction exposed to (LA) AgNPs (4.2 105 ±
3.6 104) was comparable to the number of par-
ticles detected in the cells exposed to (Cit) AgNPs
(4.4 105 ± 6 104).
The cellular fraction exposed to pristine AgNO3
contained particulate Ag with a median size of
30 nm (Figure 6(c)), while the pristine AgNO3 solu-
tion did not contain particles (Figure 5(c)). Upon
exposure to IVD AgNO3 solution, the cellular frac-
tion contained silver particulates with a median size
of 50 nm (Figures 5(f) and 6(F)). The number of par-
ticles measured in the cellular fraction upon expos-
ure to AgNPs and AgNO3 are presented in
Supplementary Material, Table S1. All the size distri-
butions of the three concentrations of AgNPs were
following similar trend, accordingly all the size dis-
tributions reported in Figure 6 are only for of
500 mg/L of AgNPs and 250 mg/L AgNO3 for simpli-
city and clarity purposes.
Discussion
This study aimed to investigate the impact of the
different biochemical conditions within the human
digestive tract – mimicked in in vitro incubations –
on the intestinal fate and subsequent cellular
uptake/association and passage across a monolayer
of differentiated Caco-2/HT29-MTX intestinal cells.
We observed that a significant fraction of the AgNPs
dissolved after the in vitro digestion. Exposure of the
monolayers of intestinal cells to increasing concen-
trations of pristine AgNPs resulted in a concentration
dependent increase of total Ag and AgNPs contents
in the cellular fractions. These concentrations were
significantly lower following the exposure to the IVD
AgNPs. Finally, passage of silver as total Ag or AgNPs
was not detectable following the exposure to either
pristine or IVD AgNPs.
The in vitro digestion model used here was
adopted from the model described by Versantvoort
et al. (Versantvoort et al. 2005; Walczak et al. 2012).
The pH in the gastric digestion phase was set at
5 ± 0.5 to simulate the gastric environment upon
ingestion of a meal (Gardner, Ciociola, and
Robinson 2002; Minekus et al. 2014; Richardson and
Feldman 1986). While this is the most realistic
exposure scenario, it might underestimate the dis-
solution of AgNPs if consumed in fasted (empty
stomach) conditions, where the stomach pH is
lower (pH 2) (Liu et al. 2012). Before in vitro diges-
tion (i.e. the pristine suspensions), both AgNPs sus-
pensions contained similar masses of total Ag and
AgNPs, indicating that before in vitro digestion, the
silver was present mainly in particulate form. In
addition, the spICP-MS derived size distributions of
both AgNPs suspensions were highly comparable.
Upon completion of all three digestion phases
(oral, gastric and intestinal), the total Ag content in
both of the IVD AgNPs suspensions and the AgNO3
solution was similar to that of the corresponding
pristine suspensions and solution, except for the
highest concentration of both AgNPs, with the total
Ag content being 10% and 40% lower for (LA)
and (Cit) AgNPs, respectively. The reduction in total
Ag content of samples taken from the highest con-
centrations could be due to a lower (analytical)
recovery due to adsorption of AgNPs to the diges-
tion matrix and tubing, and/or to the short centrifu-
gation step applied to the AgNPs samples after
digestion to spin down large protein precipitates
before ICP-MS measurement (Versantvoort et al.
2005) to which the AgNPs could potentially
adsorbed (Noireaux et al. 2019). This centrifugation
set is required to avoid the presence of large pro-
teins that destabilize the plasma of the ICP-MS
(Noireaux et al. 2019). On the other hand, a signifi-
cant reduction in the mass- and number-based
AgNPs content was observed for both AgNPs upon
completion of all digestion phases, demonstrating
that the in vitro digestion could induce dissolution,
aggregation, or protein binding of the AgNPs
(B€ohmert et al. 2014). Significantly more of the (Cit)
AgNPs endured the digestion conditions than the
(LA) AgNPs, which is most likely due to the differen-
ces in surface chemistry of the AgNPs which is influ-
encing the adsorption and agglomeration
characteristics of the AgNPs. For example, the dis-
solution of (Cit) AgNPs in fresh river water was
reported by Li and Lenhart to be much slower than
that of tween coated AgNPs, where (Cit) AgNPs
needed an incubation of 15 days to dissolve to the
same extent as the tween coated AgNPs within
6 hours (Li and Lenhart 2012). Besides, in cell cul-
ture medium, (Cit) AgNPs have been shown to dis-
solve much slower compared to 5-kDa PEG-thiol-
coated AgNPs (Zook et al. 2011). Dissolution of (LA)
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coated AgNPs, reported in the present study, has
not been studied before.
Interestingly, a significant number of silver par-
ticles was detected in the AgNO3 solution after in
vitro digestion, whereas in its pristine solution no
particles were detected. The digestive juices have a
high ionic strength including a high concentration of
chloride, which is known to form particulate com-
plexes with silver ions or the de novo formed AgNPs
(Huynh and Chen 2011; Zook et al. 2011). This could
explain the higher amount detected of cellular de
novo formed AgNPs upon exposure to pristine
AgNO3 than exposure to IVD AgNO3. Formation of
de novo complexes of silver ions with chloride, sulfur
or thiocyanate has been described before both in
vitro (K€astner, Lampen, and Th€unemann 2018;
Walczak et al. 2012; Wildt et al. 2016) and in vivo
(Levard et al. 2011; Loeschner et al. 2011).
In the present study, we used monolayers of dif-
ferentiated Caco-2/HT29-MTX cells. The presence of
mucus producing cells increases the physiological
relevance of the model compared to using Caco-2
cells alone (Georgantzopoulou et al. 2015; Hilgendorf
et al. 2000; Mahler, Shuler, and Glahn 2009; Yuan
et al. 2013). Non-cytotoxic concentrations of AgNPs
(and ionic controls) were used in our study. As
chyme from the in vitro digestion model results in
cytotoxic responses, the chyme was diluted in a 1:9
ratio with cell culture medium as described previ-
ously to avoid any cytotoxic effects (B€ohmert et al.
2014; Lichtenstein et al. 2015; Walczak, Kramer,
Hendriksen, Helsdingen, et al. 2015a).
After 24 hours of exposure to suspension of three
concentrations of either pristine or IVD AgNPs, the
total Ag and AgNPs contents of the cellular fraction
increased in a concentration dependent manner.
Both the total Ag and AgNPs contents in the cellu-
lar fractions were significantly lower following
exposure to IVD AgNPs compared to the exposure
to similar concentrations of pristine suspensions of
AgNPs. Similar observations were reported for a dif-
ferentiated Caco-2 cell model exposed to pristine
and IVD AgNPs, although in that study only the
total Ag content was measured (Lichtenstein et al.
2015). Furthermore, cellular uptake of total and par-
tiulate silver or titanium was also shown to be con-
centration dependent after 24 hours exposure in
Neuro-2a cells (Hsiao et al. 2016).
The total Ag concentration found in the cellular
fraction was in general higher than the AgNPs con-
centration, whereas upon digestion, the total Ag and
AgNPs levels in the cellular fractions were highly
comparable. As AgNPs tends to dissolve intracellu-
larly (Singh and Ramarao 2012) and form protein
corona upon IVD (Walczak, Kramer, Hendriksen,
Helsdingen, et al. 2015a), it is likely that the in vitro
digestion is protecting the AgNPs from dissolving
inside the cells. In general, the AgNPs content in the
cellular fraction appeared to be higher in the (LA)
AgNPs samples than in the (Cit) AgNPs samples, fol-
lowing exposure to pristine AgNPs. The difference in
the cellular total Ag content between (LA) and (Cit)
AgNPs could be explained by possible formation of
different types of protein coronas on the AgNPs due
to their differences in surface chemistry, as previ-
ously described for AgNPs and other NPs
(Abdelkhaliq et al. 2018; Lesniak et al. 2012;
Monteiro-Riviere et al. 2013; Tenzer et al. 2013).
Another factor influencing the interaction of AgNPs
with cells could be the stability of the coating which
might be affected by the ionic strength, protein con-
tent, or pH of the medium (Sharma et al. 2014).
Although spICP-MS is a very sensitive technique to
quantify total Ag and AgNPs concentrations, it does
not provide insights in the (sub)cellular localization of
the Ag. Here, the confocal imaging showed that a
fraction of the AgNPs was internalized in the cells.
Following exposure of the monolayers to AgNO3
(pristine and IVD), AgNPs were detected in the cell
fraction which suggests the de novo formation of
AgNPs. However, the sizes of these AgNPs differed
with a peak shift from 30nm in the pristine samples
to 50 nm in the digested samples. The de novo
AgNPs are most likely to be firstly formed as silver
salt complexes following the in vitro digestion and
upon cellular exposure and internalization, these
complexes may further interact with other cellular
molecules rich in sulfur (i.e. cysteine and glutathi-
one) and grow forming de novo nanoparticles in
situ (Loeschner et al. 2011; Maurer et al. 2014; Wildt
et al. 2016).
Lastly, we assessed the passage of total Ag and
AgNPs across the monolayers of Caco-2/HT29-MTX
cells. We performed all our experiments in trans-
wells, and sampled the basolateral compartment
following an exposure to both pristine and IVD
AgNPs suspensions; the transport of silver as either
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total Ag or AgNPs was < 0.1%. From an analytical
perpective, the sensitivity and power of the meth-
ods used for detection and quantification of Ag and
AgNPs (ICP-MS and spICP-MS respectively) were
high compared to other methods that have been
used before. That explains, why we could use low
exposure concentrations (i.e. 250 mg/L), and still
were able to detect total Ag and AgNPs in the cel-
lular fractions. Other studies reported that the silver
content in the cellular fractions after a higher
exposure concentration (i.e. 1000 mg/L) of either
pristine or IVD AgNO3 solutions for the same expos-
ure time was lower than the LOQ (20mg/cm2)
(Lichtenstein et al. 2015).
In addition, the basolateral samples were screened
for AgNPs using TEM-EDS, but again no particles
were detected. Previously, we have shown minimal
passage (less than 1%) of smaller (20 nm) AgNPs
across a monolayer of Caco-2/M-cells exposed for 4 h
(Bouwmeester et al. 2011). For larger AgNPs it can
be expected that the passage/transport is lower, in
addition, we currently used membranes with a
smaller pore size that might hinder the transport of
the AgNPs (Cartwright et al. 2012). However, in vivo
studies indicate that silver can reach the systemic cir-
culation, as oral feeding studies with rodents have
reported low oral bioavailability of silver after expos-
ure to AgNPs of different sizes (Loeschner et al.
2011; van der Zande et al. 2012).
The Caco-2/HT29-MTX intestinal model shows
potential for screening AgNPs. Addition of M-cells
to the model is not of added value in the current
case, as it was reported before to reduce the trans-
port of NPs to a similar level of transport through
Caco-2 monolayer where no mucus is present
(Walczak, Kramer, Hendriksen, Tromp, et al. 2015b).
In another study, AgNPs transport via a Caco-2/M-
cell intestinal model could be detected
(Bouwmeester et al. 2011) but the AgNPs used
were of smaller size and in pristine status which
might facilitate the possibility of detection.
Applying longer exposure periods or higher non-
toxic concentrations of AgNPs might increase the
chance of detecting and quantifying transported
AgNPs, owing to the limitation of the AgNPs stock
concentration and the necessity to high dilution
upon the digestion to avoid chyme toxicity. The
broad spectrum of AgNPs with diverse physico-
chemical characteristics might exhibit different
behaviors upon in vitro digestion and intestinal
uptake and transport which highlight the import-
ance of detailed characterization of AgNPs studied
and the difficulty to group the AgNPs.
Conclusions
The surface chemistry of AgNPs had a significant
influence on their dissolution and on their bio-
logical interactions with the Caco-2/HT29-MTX intes-
tinal model. The (LA) AgNPs dissolved to a
significantly higher extent during the digestion pro-
cess compared to (Cit) AgNPs. Cellular uptake/asso-
ciation was in general higher for the (LA) AgNPs,
although this difference disappeared after digestion.
Upon in vitro digestion, the cellular uptake/associ-
ation of both AgNPs decreased compared to the
cellular uptake/association of pristine AgNPs.
Transport of AgNPs across the monolayers of intes-
tinal cells was < 0.1%. De novo formation of AgNPs
was shown in the suspensions and in the cellular
fractions upon digestion and cellular exposure of
cells to AgNPs and AgNO3.
The combination of in vitro digestion and intes-
tinal barrier models used here confirms the interfer-
ence and the influence of the digestion process on
the biological interaction of the AgNPs upon oral
ingestion. This highlights the need to take in vitro
digestion into account when studying nanoparticle
toxicokinetics and toxicodynamics in cellular in vitro
model systems. Additionally, this combination is of
added value to the safer-by-design NP development
by identifying the physicochemical property (here
the surface chemistry) that affects the uptake/asso-
ciation and cellular internalization.
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